Literature DB >> 15005215

Atrial fibrillation in heart failure: prognostic significance and management.

Gerald V Naccarelli1, B John Hynes, Deborah L Wolbrette, Luna Bhatta, Mazhar Khan, Soraya Samii, Jerry C Luck.   

Abstract

AF in Heart Failure. Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15005215     DOI: 10.1046/j.1540-8167.2003.90404.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  9 in total

1.  Unusual echocardiographic features seen in a case of giant cell myocarditis.

Authors:  Minisha Kochar; Angel López-Candales; Gautam Ramani; Navin Rajagopalan; Kathy Edelman
Journal:  Can J Cardiol       Date:  2008-11       Impact factor: 5.223

2.  Advanced Interatrial Block Predicts New Onset Atrial Fibrillation in Patients with Severe Heart Failure and Cardiac Resynchronization Therapy.

Authors:  Fariha Sadiq Ali; Andres Enriquez; Diego Conde; Damian Redfearn; Kevin Michael; Christopher Simpson; Hoshiar Abdollah; Antoni Bayés de Luna; Wilma Hopman; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-02       Impact factor: 1.468

Review 3.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

4.  The management of atrial fibrillation in heart failure.

Authors:  Rupa Bala; David J Callans
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

5.  Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction.

Authors:  Aiman Smer; Mohsin Salih; Yousef H Darrat; Abdulghani Saadi; Raviteja Guddeti; Toufik Mahfood Haddad; Amjad Kabach; Mohamed Ayan; Alok Saurav; Hussam Abuissa; Claude S Elayi
Journal:  Clin Cardiol       Date:  2018-11-19       Impact factor: 2.882

6.  Treatment of Arrhythmias in Patients with Congestive Heart Failure.

Authors:  Robert M Lobel; Daniel L Lustgarten
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12

7.  Atrial overdrive pacing and incidence of heart failure-related adverse events in permanently paced patients.

Authors:  Andreas Schuchert; Mark Carlson; John Ip; John Messenger; Scott Beau; Steven Kalbfleisch; Pierre Gervais; Douglas A Cameron; Aurelio Duran; Jesus Val-Mejias; Judith Mackall; Michael Gold
Journal:  J Interv Card Electrophysiol       Date:  2007-06-29       Impact factor: 1.900

8.  Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation.

Authors:  Nicolás Vecchio; Leonardo Ripa; Agustín Orosco; Leandro Tomas; Ignacio Mondragón; Adriana Acosta; Lujan Talavera; Santiago Rivera; Gastón Albina; Mirta Diez; Fernando Scazzuso
Journal:  J Atr Fibrillation       Date:  2019-02-28

9.  Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study.

Authors:  Yoko Shibata; Tetsu Watanabe; Daisuke Osaka; Shuichi Abe; Sumito Inoue; Yoshikane Tokairin; Akira Igarashi; Keiko Yamauchi; Tomomi Kimura; Hiroyuki Kishi; Yasuko Aida; Keiko Nunomiya; Takako Nemoto; Masamichi Sato; Tsuneo Konta; Sumio Kawata; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  Int J Med Sci       Date:  2011-08-29       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.